GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 2,197 Value ($000) $0 Avg Close — Range —
Q3 2023
Shares 2,436 Value ($000) $0 Avg Close — Range —
Q2 2023
Shares 3,819 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 2,508 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 281,958 Value ($000) $250 Avg Close — Range —
Q3 2022
Shares 2,068 Value ($000) $3 Avg Close — Range —
Q2 2022
Shares 1,958 Value ($000) $6 Avg Close — Range —
Q1 2022
Shares 3,049 Value ($000) $9 Avg Close — Range —
Q4 2021
Shares 6,377 Value ($000) $20 Avg Close — Range —
Q3 2021
Shares 4,134 Value ($000) $28 Avg Close — Range —
Q2 2021
Shares 3,590 Value ($000) $55 Avg Close — Range —
Q1 2021
Shares 24,542 Value ($000) $167 Avg Close — Range —